Hypericum perforatum use during pregnancy and pregnancy outcome

Reproductive Toxicology

Volumn 58, Issue , 2015, Pages 234-237

  Kolding, Line ^a   Pedersen, Lars Henning ^a   Henriksen, Tine Brink ^b   Olsen, Jørn ^c   Grzeskowiak, Luke E ^d  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Birth outcomes; Human pregnancy; Hypericum perforatun; Malformations; St. John's Wort

Indexed keywords

HERBACEOUS AGENT; ANTIDEPRESSANT AGENT; PLANT EXTRACT;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HEART SEPTUM DEFECT; HIP DISLOCATION; HUMAN; HYPERICUM PERFORATUM; HYPOSPADIAS; INFANT; MALE; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; PRENATAL DRUG EXPOSURE; PREVALENCE; PUERPERAL DEPRESSION; SPONTANEOUS ABORTION; STILLBIRTH; TREATMENT OUTCOME; ABNORMALITIES, DRUG-INDUCED; ADVERSE EFFECTS; CHEMICALLY INDUCED; CHEMISTRY; DENMARK; FACTUAL DATABASE; HYPERICUM; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PHYTOTHERAPY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTIDEPRESSIVE AGENTS; DATABASES, FACTUAL; DENMARK; FEMALE; HUMANS; HYPERICUM; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84946552529     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2015.10.003     Document Type: Article

References (17)

1. Goldman R.D., Koren G., Motherisk T. Taking St. John's wort during pregnancy. Can. Fam. Phys. 2003, 49:29-30.
2. Solomon D., Ford E., Adams J., Graves N. Potential of St. John's Wort for the treatment of depression: the economic perspective. Aust. N. Z. J. Psychiatry 2011, 45(2):123-130.
3. Howland R.H. Update on St. John's Wort. J. Psychosoc. Nurs 2010, 48:11.
4. Moretti M.E., Maxson A., Hanna F., Koren G. Evaluating the safety of St. John's Wort in human pregnancy. Reprod. Toxicol. 2009, 28(1):96-99.
5. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in Pregnancy and Lactation 2011, Lippincott, Williams, Wilkins.
6. Grush L.R., Nierenberg A., Keefe B., Cohen L.S. St. John's wort during pregnancy. JAMA 1998, 280(18):1566.
7. Olsen J., Melbye M., Olsen S.F., Sorensen T.I., Aaby P., Andersen A.M., Taxbol D., Hansen K.D., Juhl M., Schow T.B., et al. The Danish National Birth Cohort-its background, structure and aim. Scand. J. Public Health 2001, 29(4):300-307.
8. Pedersen L., Henriksen T., Olsen J. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 2010, 125(3):e600-e608.
9. Lechat M.F., Dolk H. Registries of congenital anomalies: EUROCAT. Environ. Health Perspect. 1993, 101(Suppl. 2):153-157.
10. Lund L., Engebjerg M.C., Pedersen L., Ehrenstein V., Norgaard M., Sorensen H.T. Prevalence of hypospadias in Danish boys: a longitudinal study, 1977-2005. Eur. Urol. 2009, 55(5):1022-1026.
11. Pedersen L.H., Henriksen T.B., Vestergaard M., Olsen J., Bech B.H. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009, 339:b3569.
12. Rahimi R., Abdollahi M. An update on the ability of St. John's wort to affect the metabolism of other drugs. Expert Opin. Drug Metabol. Toxicol. 2012, 8(6):691-708.
13. Grzeskowiak L.E., Gilbert A.L., Morrison J.L. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors. J. Clin. Psychopharmacol. 2012, 32(5):615-621.
14. Lund N., Pedersen L.H., Henriksen T.B. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Archives Pediatr. Adolesc. Med. 2009, 163(10):949-954.
15. Nohr E.A., Frydenberg M., Henriksen T.B., Olsen J. Does low participation in cohort studies induce bias?. Epidemiology 2006, 17(4):413-418.
16. Bech B.H., Nohr E.A., Vaeth M., Henriksen T.B., Olsen J. Coffee and fetal death: a cohort study with prospective data. Am. J. Epidemiol. 2005, 162(10):983-990.
17. Grzeskowiak L.E., Gilbert A.L., Morrison J.L. Investigating outcomes associated with medication use during pregnancy: a review of methodological challenges and observational study designs. Reprod. Toxicol. 2012, 33(3):280-289.